Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment

Clinical trial NCT01316055 · COMPLETED

Trial details

NCT number: NCT01316055
Sponsor: Acorda Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Insufficiency

Start date: 2011-01-01
Primary completion: 2011-08-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.